These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25144411)

  • 1. Novel platelet storage conditions: additive solutions, gas, and cold.
    Capocelli KE; Dumont LJ
    Curr Opin Hematol; 2014 Nov; 21(6):491-6. PubMed ID: 25144411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of additive solutions for platelets.
    Alhumaidan H; Sweeney J
    J Clin Apher; 2012; 27(2):93-8. PubMed ID: 22298435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet storage lesion.
    Devine DV; Serrano K
    Clin Lab Med; 2010 Jun; 30(2):475-87. PubMed ID: 20513565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold stored platelets in the management of bleeding: is it about bioenergetics?
    George CE; Saunders CV; Morrison A; Scorer T; Jones S; Dempsey NC
    Platelets; 2023 Dec; 34(1):2188969. PubMed ID: 36922733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans and glycosylation of platelets: current concepts and implications for transfusion.
    Sørensen AL; Hoffmeister KM; Wandall HH
    Curr Opin Hematol; 2008 Nov; 15(6):606-11. PubMed ID: 18832932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold-Stored Platelets: Review of Studies in Humans.
    Mack JP; Miles J; Stolla M
    Transfus Med Rev; 2020 Oct; 34(4):221-226. PubMed ID: 33039263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in transfusion for storage of platelets].
    Cazenave JP; Isola H; Gachet C; Aleil B
    Transfus Clin Biol; 2005 Jun; 12(2):226-9. PubMed ID: 15950893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates.
    Marini I; Aurich K; Jouni R; Nowak-Harnau S; Hartwich O; Greinacher A; Thiele T; Bakchoul T
    Haematologica; 2019 Jan; 104(1):207-214. PubMed ID: 30115655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances of studies on platelet additive solutions - review].
    Hu WB; Han Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):721-4. PubMed ID: 18549662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiology of cold-stored platelets.
    Getz TM
    Transfus Apher Sci; 2019 Feb; 58(1):12-15. PubMed ID: 30639086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).
    Azuma H; Hirayama J; Akino M; Miura R; Kiyama Y; Imai K; Kasai M; Koizumi K; Kakinoki Y; Makiguchi Y; Kubo K; Atsuta Y; Fujihara M; Homma C; Yamamoto S; Kato T; Ikeda H
    Transfusion; 2009 Feb; 49(2):214-8. PubMed ID: 18798806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
    Vassallo RR; Adamson JW; Gottschall JL; Snyder EL; Lee W; Houghton J; Elfath MD
    Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
    Diedrich B; Ringdén O; Watz E; Shanwell A
    Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
    Valeri CR; Ragno G
    Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current advance of blood preservation--development and clinical application of additive solutions for preservation of red blood cells and platelets].
    Yasutake M; Takahashi TA
    Nihon Rinsho; 1997 Sep; 55(9):2429-33. PubMed ID: 9301312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoid-mediated inhibition of actin polymerization in cold-activated platelets.
    Pastore JJ; Funaki M; Janmey PA; Bucki R
    Platelets; 2005 Sep; 16(6):362-7. PubMed ID: 16194866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold-stored platelets: A product with function optimized for hemorrhage control.
    Reddoch-Cardenas KM; Bynum JA; Meledeo MA; Nair PM; Wu X; Darlington DN; Ramasubramanian AK; Cap AP
    Transfus Apher Sci; 2019 Feb; 58(1):16-22. PubMed ID: 30704925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].
    Rebibo D; Simonet M; Hauser L
    Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
    Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T
    Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic energy reduction by glucose deprivation and low gas exchange preserves platelet function after 48 h storage at 4 degrees C.
    Badlou BA; van der Meer PF; Akkerman JW; Smid WM; Pietersz RN
    Vox Sang; 2007 May; 92(4):311-8. PubMed ID: 17456155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.